Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
America's patent system is at a crossroads. There are many critics of the patent system; some have become increasingly vocal. Some claim the patent system is outdated. Others label it as a “threat to innovation.” As fodder for their arguments, critics often tout examples of one or more patents that, in the words of one academic, are “not new, are obvious, are laughably insipid or sometimes all of the above” (“Patent Prescription: A radical cure for the ailing U.S. patent system,” A. Jaffe and J. Lerner, IEEE Spectrum Online, Dec. 10, 2004).
While one can argue the merits of the particular patents in question, most agree that U.S. economic productivity and competitiveness are based on our ability to innovate. Innovation, however, can only be possible if there is a rigorous intellectual property regime that protects inventors. A sound patent system is a critical part of that regime.
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.